Structure via PubChem · Public domain (PubChem)
Chemical data
- Formula
- C35H45Cl2NO6
- Molecular weight
- 646.6 g/mol
- IUPAC name
- [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 4-[4-[bis(2-chloroethyl)amino]phenyl]butanoate
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
- Indications
- lymphoma, neoplasm
via ChEMBL · EBI
Research
189 papers- Prednimustine.IARC monographs on the evaluation of carcinogenic risks to humans · 1990
- Prednimustine.Seminars in oncology · 1986
- Prednimustine in advanced breast cancer: a review.Seminars in oncology · 1986
- [Myoclonus induced by prednimustine].Neurologia (Barcelona, Spain) · 1998
- Prednimustine treatment in malignant lymphomas.Oncology · 1989
via PubMed
Article · Français
La Prednimustine est un médicament utilisé en chimiothérapie dans le traitement des leucémies et des lymphomes. C'est un ester formé à partir de la prednisolone et du chlorambucil.
Abstract from DBpedia / Wikipedia · CC BY-SA
Available in 7 languages
via Wikidata sitelinks · CC0